SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXYS Pharmaceuticals Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (23)1/14/1998 11:31:00 PM
From: Pseudo Biologist  Read Replies (1) of 455
 
Andy, funny thing they did not say in the press release, because from the patent numbers one can figure it out. For example, for the first patent:

5686598 : Genes associated with retinal dystrophies
------------------------------------------------------------------------
INVENTORS:North; Michael, San Diego, CA
Nishina; Patsy, Bar Harbor, ME
Naggert; Juergen, Bar Harbor, ME
ASSIGNEES:The Jackson Laboratory, Bar Harbor, MESequana Therapeutics, Inc., La Jolla, CAISSUED:Nov.ÿ11, 1997ÿFILED: Aug.ÿ22, 1996

And the second one:

5705380 : Identification of a gene encoding TULP2, a retina specific protein
------------------------------------------------------------------------
INVENTORS:North; Michael, San Diego, CA
Nishina; Patsy, Bar Harbor, ME
Naggert; Juergen, Bar Harbor, ME
ASSIGNEES:Sequana Theraputics, Inc., La Jolla, CAJackson Lab., Bar Harbor, MEISSUED:Jan.ÿ6 , 1998ÿFILED: Sep.ÿ4 , 1996

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News